CML - Chronic myeloid leukemia

  1. Persistence of major molecular remission (MR3) in chronic myeloid leukemia after a second stop of TKI treatment in patients who failed an initial stop attempt. DASTOP2
    Primary researcher: Satu Mustjoki
 

 Contact information

 
haluantutkimuspotilaaksi@hus.fi
tel. +358 50 427 0680